Search Results - "Oe, LP"

Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial) by de Fijter, CW, ter Wee, PM, Oe, LP, Verbrugh, HA

“…Department of Nephrology, Free University Medical Center, Amsterdam, The Netherlands. c.w.h.defijter@olvg.nl…”
Get full text

Low-calcium peritoneal dialysis fluid should not impact peritonitis rates in continuous ambulatory peritoneal dialysis by de Fijter, C W, Oe, L P, Heezius, E C, Donker, A J, Verbrugh, H A

“…It has been suggested that reducing the calcium content of peritoneal dialysis fluid (PDF) to 2.5 mEq/L decreases peritoneal macrophage (PMO) function and…”
Get more information

Does additional treatment with fish oil mitigate the side effects of recombinant human erythropoietin in dialysis patients? by de Fijter, CW, Popp-Snijders, C, Oe, LP, Tran, DD, van der Meulen, J, Donker, AJ

“…Department of Internal Medicine, Free University Hospital, Amsterdam, The Netherlands. Since fish oil has been reported to reduce platelet aggregability, to…”
Get full text

Adipose tissue fatty acid composition and its relations to diet and plasma lipid concentrations in hemodialysis patients by de Vries, PM, Folkers, HB, de Fijter, CW, van der Meulen, J, Luitingh-van der Veen, M, Popp-Snijders, C, Oe, LP

“…Adipose tissue fatty acid composition, serum lipid profile, and dietary intake of 37 patients on maintenance hemodialysis were studied. In August 1982, 1984,…”
Get full text

Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis by DE FIJTER, C. W. H, OE, L. P, NAUTA, J. J. P, VAN DER MEULEN, J, VERBRUGH, H. A, VERHOEF, J, DONKER, A. J. M

“…To assess the clinical efficacy and morbidity of continuous cyclic peritoneal dialysis compared with continuous ambulatory peritoneal dialysis with a…”
Get full text

Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid by de Fijter, C W, Verbrugh, H A, Oe, L P, Heezius, E, Donker, A J, Verhoef, J, Gokal, R

“…The currently available glucose-containing peritoneal dialysis fluids (PDF), which are all hyperosmolar, are toxic to the cells present in the peritoneal…”
Get more information

Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis by de Fijter, Carola W.H., Verbrugh, Henri A., Oe, Liem P., Peters, Edith D.J., van der Meulen, Jan, Donker, Ab J.M., Verhoef, Jan

“…Peritoneal defense in continuous ambulatory peritoneal dialysis versus continuous cyclic peritoneal dialysis. Several centers have reported a lower rate of…”
Get full text

Effect of glucose in dialysis fluid on antibacterial defence in the peritoneal cavity by Calame, Wim, Hendrickx, Roeland J.B.M., Namavar, Ferry, Oe, Liem P., Beelen, Robert H.J.

“…To study the effect of glucose concentration and dwell time of dialysis fluid on peritoneal antibacterial defence, an experimental infection with…”
Get full text

Doxazosin in the treatment of patients with mild or moderate hypertension and mild or moderate renal insufficiency by Bartels, A C, de Vries, P M, Oe, L P, van Bronswÿk, H, Donker, A J, Réveillaud, R J, Fillastre, J P, Zech, P

“…The antihypertensive efficacy and safety of doxazosin, a selective alpha 1-inhibitor, were assessed in 23 hypertensive patients with renal insufficiency. The…”
Get more information

Short dwell times reduce the local defence mechanism of chronic peritoneal dialysis patients by Vlaanderen, K, Bos, H J, de Fijter, C W, Oe, L P, van der Meulen, J, Verbrugh, H A, Beelen, R H

“…The effect of different intraperitoneal dwell times on the phagocytic capacity of the effluent-derived macrophages in 6 peritoneal dialysis patients was…”
Get more information

Effect of glucose concentration and dwell time of dialysis fluid on the antibacterial defense in the peritoneal cavity of rats by Calame, W, Hendrickx, R J, Oe, L P, Namavar, F, Beelen, R H

“…To study the influence of dialysis fluid on the antibacterial defense in the peritoneal cavity of rats, especially glucose concentration and dwell time, an…”
Get full text

Pharmacokinetics of ciprofloxacin after intraperitoneal administration in uninfected patients undergoing CCPD by de Fijter, C W, Biemond, A, Oe, L P, Moesker, H L, Verhoef, J, Donker, A J, Verbrugh, H A

“…Ciprofloxacin is increasingly used to treat peritoneal dialysis related peritonitis. We studied the pharmacokinetics of intraperitoneally administered…”
Get full text